Omada Health
OMDA

Omada Health (OMDA) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
Freedom Capital MarketsMaintainedBuy$35.00Sep 14, 2026
BTIGMaintainedBuy$35.00Sep 11, 2026
BarclaysMaintainedOverweight$27.00 from $25.00Sep 11, 2026
NeedhamMaintainedBuy$28.00Sep 11, 2026
CitizensMaintainedMarket Outperform$32.00 from $27.00Aug 14, 2026
JP MorganMaintainedOverweight$30.00 from $26.00Aug 14, 2026
BairdMaintainedNeutral$25.00 from $15.00Aug 12, 2026
BTIGMaintainedBuy$35.00 from $30.00Aug 10, 2026
BarclaysMaintainedOverweight$25.00 from $20.00Aug 3, 2026
Canaccord GenuityMaintainedBuy$28.00 from $24.00Jul 21, 2026
CitizensMaintainedMarket Outperform$27.00 from $21.00Jul 20, 2026
BTIGInitiated CoverageBuy$30.00Jul 17, 2026
Morgan StanleyMaintainedOverweight$30.00Jun 22, 2026
Wells FargoMaintainedEqual-Weight$18.00 from $17.00May 8, 2026
Evercore ISI GroupMaintainedOutperform$20.00 from $15.00May 8, 2026
BarclaysMaintainedOverweight$20.00 from $18.00May 8, 2026
NeedhamMaintainedBuy$28.00May 8, 2026
CitizensMaintainedMarket Outperform$21.00 from $18.00May 8, 2026
CitizensInitiated CoverageMarket Outperform$18.00Apr 14, 2026
Goldman SachsMaintainedBuy$23.00 from $26.00Apr 9, 2026

Frequently asked questions

  • What is the latest analyst rating on OMDA?

    On Sep 14, 2026, Freedom Capital Markets maintained Omada Health at Buy with a price target of $35.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.